About Vascular Control Systems
Vascular Control Systems is a Healthcare company based in San Juan Capistrano (United States) founded in 2008 by Michael Jones, and was acquired by Ethicon in May 2006. A minimally-invasive uterine artery occlusion treatment device. The company was acqui-hired. Its focus areas include Life Sciences, Women Health, Medical Devices and Screening Devices. Its competitors include Gynesonics, Channel Medsystems and Minerva Surgical; 3 of its 3 listed competitors have raised funding.
Company details
Vascular Control Systems (formerly known as HysteRx) develops devices for the treatment of fibroids and bleeding control devices used in obstetric and gynecologic applications. The company has developed a minimally-invasive uterine artery occlusion treatment device. The company was acquired by Ethicon (JJ) in May, 2006.
- Headquarters San Juan Capistrano, United States
- Founders Michael Jones
- Stage Acquired
- SectorsHealthcare
- Website vascularcontrol.com
- Social LinkedIn
- Acquired by Ethicon (May 2006)
Investors in Vascular Control Systems
Vascular Control Systems has secured backing from 1 investor. Prominent investors backing the company include Ethicon.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Specializes in surgical sutures and wound closure devices. | 1886 | ethicon.com | Cincinnati, United States |
Investor details for Vascular Control Systems
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Vascular Control Systems
1 people are tracked at Vascular Control Systems (1 in leadership).
| Name | Role | Group |
|---|---|---|
Michael Jones | Founder | Leadership |
Complete people profiles for Vascular Control Systems
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Vascular Control Systems
2 dated milestones of Vascular Control Systems across 2 years, from founding to its latest funding, stage changes and deals.
- Exit Acquired by Ethicon.
- Founded Vascular Control Systems is founded.
Competitors of Vascular Control Systems
Vascular Control Systems has 3 listed competitors in our database, 3 of them funded. They include Gynesonics, Channel Medsystems and Minerva Surgical.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| gynesonics.com | 2005 | Redwood, United States | $282.54M | 92 | A minimally invasive ablation system for uterine fibroids is developed. | |
| channelmedsystems.com | 2009 | San Francisco, United States | $47.67M | 37 | Cryothermic technology for endometrial ablation to control heavy bleeding | |
| minervasurgical.com | 2008 | Redwood, United States | $135.1M | 155 | Minerva Surgical is focused on uterine health solutions. |
Detailed competitors of Vascular Control Systems
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Women's Health & Fertility
3 companies that operate in the same segment as Vascular Control Systems (Women's Health & Fertility) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of cell-free DNA testing for oncology, women’s health, and organ health | 2004 | Redwood City, California, United States | USD 152.1 M | USD 2.31 B | 4,430 | |
Therapeutics for women's healthcare are developed and offered. | 1997 | Princeton, New Jersey, United States | USD 123.06 M | USD 19.59 M | ||
Provider of cell-free cancer liquid biopsy test | 2015 | San Francisco, California, United States | USD 388.62 M | 861 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Vascular Control Systems
Vascular Control Systems was founded in 2008.
Vascular Control Systems is headquartered in San Juan Capistrano, United States. It is registered at San Juan Capistrano, California, United States.
Vascular Control Systems (formerly known as HysteRx) develops devices for the treatment of fibroids and bleeding control devices used in obstetric and gynecologic applications. The company has developed a minimally-invasive uterine artery occlusion treatment device. The company was acquired by Ethicon (JJ) in May, 2006.
Vascular Control Systems's top competitors include Gynesonics, Channel Medsystems and Minerva Surgical.
Vascular Control Systems has 1 investor. Key investors include Ethicon.
Yes. Vascular Control Systems was acquired by Ethicon in May 2006.